INSM
Insmed Incorporated
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Sell
-43/100
Last price
106.50
▲ 2.67 (2.57%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
105.19
Prev close
103.83
Day high
107.87
Day low
101.37
Volume
3.69M
Market cap
$22.98B
P/E (TTM)
—
52W range
90.39 – 212.75
Day trading desk
Gap from prior close
+1.31%
Prior close 103.83
VWAP
104.83
+1.59% from price
Relative volume
1.20×
Normal
Session range
6.67%
101.37 – 108.13
Position in range
76%
Near session high
ATR (14D)
5.23
4.91% of price
Prior day high
108.75
PDH
Prior day low
101.65
PDL
Bid / ask spread
—
Quote not published
Session volume
3.08M
Avg 2.56M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-8.99%
-10.9%
1M
-16.68%
-17.8%
3M
-9.70%
-14.2%
6M
-35.45%
-53.6%
YTD
-39.54%
-53.8%
1Y
-33.04%
-49.5%
3Y
+316.75%
+234.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on INSM open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-104.26K
Net selling
Buy transactions
17
401.73K shares
Sell transactions
26
506.00K shares
Net transactions
+43
Buys less sells
Sell : buy shares
1.3 : 1
Mixed
Insider-held shares
1.10M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 9, 26 | BRENNAN DAVID R Director |
SELL | 25.00K | $3.10M | Direct |
| Aug 17, 26 | SHAROKY MELVIN A Director |
SELL | 5.00K | $637.65K | Indirect |
| Aug 10, 26 | ADSETT ROGER Chief Operating Officer |
SELL | 239.85K | $31.96M | Direct |
| Aug 10, 26 | ADSETT ROGER Chief Operating Officer |
CONVERSION | 239.85K | $4.91M | Direct |
| Aug 6, 26 | FLAMMER MARTINA Officer |
SELL | 27.17K | $3.49M | Direct |
| Aug 6, 26 | FLAMMER MARTINA Officer |
CONVERSION | 27.17K | $576.13K | Direct |
| Jul 23, 26 | LEWIS WILLIAM H Chief Executive Officer |
SELL | 10.70K | $1.13M | Direct |
| Jul 23, 26 | LEWIS WILLIAM H Chief Executive Officer |
CONVERSION | 10.70K | $266.87K | Direct |
| Jul 9, 26 | LEWIS WILLIAM H Chief Executive Officer |
SELL | 10.70K | $1.26M | Direct |
| Jul 9, 26 | LEWIS WILLIAM H Chief Executive Officer |
CONVERSION | 10.70K | $266.84K | Direct |
| Jul 6, 26 | FLAMMER MARTINA Officer |
SELL | 12.30K | $1.35M | Direct |
| Jul 6, 26 | FLAMMER MARTINA Officer |
CONVERSION | 12.30K | $317.44K | Direct |
| Jun 25, 26 | LEWIS WILLIAM H Chief Executive Officer |
SELL | 21.40K | $2.21M | Direct |
| Jun 25, 26 | LEWIS WILLIAM H Chief Executive Officer |
CONVERSION | 21.40K | $533.68K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ADSETT ROGER |
Chief Operating Officer | 98.74K | Sale |
ANDERSON ELIZABETH M |
Director | 62.03K | Stock Award(Grant) |
BONSTEIN SARA M |
Chief Financial Officer | 69.08K | Sale |
BRENNAN DAVID R |
Director | 99.24K | Sale |
FLAMMER MARTINA |
Officer | 60.49K | Sale |
LEWIS WILLIAM H |
Chief Executive Officer | 492.98K | Sale |
MCGIRR DAVID W J |
Director | 97.72K | Stock Gift |
SCHAFER CAROL ANNE |
Director | 66.62K | Stock Award(Grant) |
SHAROKY MELVIN A |
Director | — | Sale |
WISE JOHN DRAYTON |
Officer | 133.01K | Sale |
Fundamentals
Market cap$22.98B
Enterprise value$22.55B
Revenue (TTM)$1.14B
Gross profit$949.42M
EBITDA$-794.96M
Net income$-875.31M
EPS (TTM)$-4.10
Free cash flow$-571.82M
Total cash$1.16B
Total debt$739.72M
Book value / share$3.47
Shares outstanding218.38M
Float216.93M
Short % of float5.57%
Dividend yield0.00%
Beta (5Y)0.82
Valuation & profitability ratios
Trailing P/E—
Forward P/E135.82
PEG ratio1.09
Price / sales—
Price / book30.33
EV / revenue19.82
EV / EBITDA-28.37
Gross margin83.45%
Operating margin-23.81%
Profit margin-76.94%
Return on equity-87.22%
Return on assets-22.17%
Debt / equity97.65
Current ratio3.72
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $606.42M | $363.71M | $305.21M | $245.36M | +66.7% |
| Operating revenue | $606.42M | $363.71M | $305.21M | $245.36M | +66.7% |
| Cost of revenue | $122.94M | $85.74M | $65.57M | $55.13M | +43.4% |
| Gross profit | $483.49M | $277.96M | $239.63M | $190.23M | +73.9% |
| Research & development | $771.09M | $598.37M | $571.01M | $397.52M | +28.9% |
| Selling, general & admin | $701.17M | $461.12M | $344.50M | $265.78M | +52.1% |
| Total operating expense | $1.48B | $1.06B | $920.56M | $668.36M | +38.9% |
| Operating income | -$994.78M | -$786.57M | -$680.93M | -$478.12M | -26.5% |
| Net interest income | -$83.80M | -$84.91M | -$81.69M | -$26.45M | +1.3% |
| Pre-tax income | -$1.27B | -$910.07M | -$747.01M | -$480.15M | -39.7% |
| Tax provision | $5.03M | $3.71M | $2.56M | $1.38M | +35.6% |
| Net income | -$1.28B | -$913.77M | -$749.57M | -$481.53M | -39.7% |
| Net income to common | -$1.28B | -$913.77M | -$749.57M | -$481.53M | -39.7% |
| Basic EPS | -6.42 | -5.57 | -5.34 | -3.91 | -15.3% |
| Diluted EPS | -6.42 | -5.57 | -5.34 | -3.91 | -15.3% |
| EBIT | -$1.19B | -$829.81M | -$670.76M | -$457.70M | -43.9% |
| EBITDA | -$1.18B | -$818.79M | -$660.18M | -$447.37M | -43.8% |
| Basic shares | 199.01M | 164.04M | 140.43M | 123.03M | +21.3% |
| Diluted shares | 199.01M | 164.04M | 140.43M | 123.03M | +21.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $510.44M | $555.03M | $482.37M | $1.07B | -8.0% |
| Accounts receivable | $140.86M | $52.01M | $41.19M | $29.71M | +170.8% |
| Inventory | $132.07M | $98.58M | $83.25M | $69.92M | +34.0% |
| Total current assets | $1.79B | $1.62B | $929.06M | $1.27B | +10.6% |
| Property, plant & equipment | $139.21M | $115.58M | $104.39M | $102.08M | +20.4% |
| Goodwill & intangibles | $233.76M | $194.76M | $199.81M | $204.87M | +20.0% |
| Total assets | $2.26B | $2.03B | $1.33B | $1.66B | +11.8% |
| Total current liabilities | $468.87M | $297.53M | $225.63M | $190.24M | +57.6% |
| Long-term debt | $540.96M | $1.10B | $1.16B | $1.13B | -51.0% |
| Total liabilities | $1.53B | $1.74B | $1.66B | $1.57B | -12.3% |
| Retained earnings | -$5.64B | -$4.36B | -$3.45B | -$2.70B | -29.3% |
| Shareholder equity | $738.98M | $285.38M | -$331.92M | $87.95M | +158.9% |
| Working capital | $1.33B | $1.32B | $703.43M | $1.08B | +0.1% |
| Net tangible assets | $505.21M | $90.62M | -$531.74M | -$116.92M | +457.5% |
| Shares issued | 214.26M | 179.38M | 147.98M | 135.65M | +19.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$1.28B | -$913.77M | -$749.57M | -$481.53M | -39.7% |
| Depreciation & amortisation | $16.45M | $11.01M | $10.58M | $10.33M | +49.4% |
| Stock-based compensation | $152.71M | $96.83M | $74.78M | $57.69M | +57.7% |
| Change in working capital | -$80.30M | -$3.18M | -$39.22M | $6.58M | -2,427.5% |
| Operating cash flow | -$935.01M | -$683.88M | -$536.25M | -$400.44M | -36.7% |
| Capital expenditure | -$32.56M | -$21.92M | -$13.29M | -$9.88M | -48.5% |
| Investing cash flow | -$64.58M | -$583.17M | -$223.60M | -$34.58M | +88.9% |
| Financing cash flow | $954.07M | $1.34B | $168.44M | $793.27M | -28.9% |
| Free cash flow | -$967.58M | -$705.80M | -$549.53M | -$410.32M | -37.1% |
| End cash position | $510.44M | $555.03M | $482.37M | $1.07B | -8.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $425.49M | $305.96M | $263.84M | $142.34M | $107.42M | +39.1% |
| Operating revenue | $425.49M | $305.96M | $263.84M | $142.34M | $107.42M | +39.1% |
| Cost of revenue | $67.21M | $47.42M | $44.22M | $29.36M | $28.07M | +41.7% |
| Gross profit | $358.27M | $258.54M | $219.62M | $112.98M | $79.34M | +38.6% |
| Research & development | $210.03M | $209.49M | $254.91M | $186.41M | $177.19M | +0.3% |
| Selling, general & admin | $247.47M | $247.26M | $212.48M | $186.38M | $154.76M | +0.1% |
| Total operating expense | $459.58M | $458.82M | $469.33M | $374.33M | $333.22M | +0.2% |
| Operating income | -$101.31M | -$200.28M | -$249.71M | -$261.35M | -$253.88M | +49.4% |
| Net interest income | -$20.27M | -$20.08M | -$20.60M | -$20.38M | -$21.25M | -1.0% |
| Pre-tax income | -$11.37M | -$162.10M | -$326.93M | -$368.70M | -$320.44M | +93.0% |
| Tax provision | $1.87M | $1.47M | $1.55M | $1.32M | $1.24M | +27.6% |
| Net income | -$13.24M | -$163.56M | -$328.49M | -$370.02M | -$321.69M | +91.9% |
| Net income to common | -$13.24M | -$163.56M | -$328.49M | -$370.02M | -$321.69M | +91.9% |
| Basic EPS | -0.06 | -0.76 | -1.54 | -1.75 | -1.70 | +92.1% |
| Diluted EPS | -0.06 | -0.76 | -1.54 | -1.75 | -1.70 | +92.1% |
| EBIT | $7.47M | -$143.40M | -$307.71M | -$349.66M | -$300.87M | +105.2% |
| EBITDA | $12.73M | -$138.38M | -$302.15M | -$345.67M | -$297.13M | +109.2% |
| Basic shares | 217.35M | 215.47M | 213.64M | 211.76M | 189.30M | +0.9% |
| Diluted shares | 217.35M | 215.47M | 213.64M | 211.76M | 189.30M | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $544.76M | $582.19M | $510.44M | $334.76M | $1.28B | -6.4% |
| Cash & short-term investments | $1.16B | $1.22B | $1.43B | $1.68B | $1.86B | -5.2% |
| Accounts receivable | $215.32M | $178.56M | $140.86M | $65.26M | $55.03M | +20.6% |
| Inventory | $142.38M | $132.91M | $132.07M | $120.97M | $107.61M | +7.1% |
| Total current assets | $1.63B | $1.61B | $1.79B | $1.93B | $2.08B | +1.3% |
| Property, plant & equipment | $134.60M | $131.73M | $139.21M | $116.62M | $117.23M | +2.2% |
| Goodwill & intangibles | $229.60M | $231.68M | $233.76M | $220.70M | $192.24M | -0.9% |
| Total assets | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | +1.3% |
| Total current liabilities | $438.74M | $361.01M | $468.87M | $417.21M | $311.68M | +21.5% |
| Long-term debt | $543.51M | $542.22M | $540.96M | $539.72M | $538.51M | +0.2% |
| Total debt | $579.88M | $580.33M | $586.67M | $576.28M | $575.51M | -0.1% |
| Total liabilities | $1.35B | $1.37B | $1.53B | $1.42B | $1.23B | -1.9% |
| Retained earnings | -$5.81B | -$5.80B | -$5.64B | -$5.31B | -$4.94B | -0.2% |
| Shareholder equity | $757.49M | $704.85M | $738.98M | $945.57M | $1.25B | +7.5% |
| Working capital | $1.20B | $1.25B | $1.33B | $1.51B | $1.77B | -4.6% |
| Net tangible assets | $527.89M | $473.17M | $505.21M | $724.87M | $1.06B | +11.6% |
| Shares issued | 218.28M | 216.52M | 214.26M | 212.58M | 211.11M | +0.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$13.24M | -$163.56M | -$328.49M | -$370.02M | -$321.69M | +91.9% |
| Depreciation & amortisation | $5.26M | $5.01M | $5.56M | $4.00M | $3.75M | +4.9% |
| Stock-based compensation | $41.25M | $45.75M | $39.04M | $31.43M | $42.98M | -9.8% |
| Change in working capital | -$24.93M | -$64.21M | -$37.64M | $13.90M | $9.54M | +61.2% |
| Operating cash flow | -$88.83M | -$222.74M | -$247.60M | -$219.76M | -$205.57M | +60.1% |
| Capital expenditure | -$6.26M | -$3.48M | -$16.59M | -$2.42M | -$3.48M | -79.9% |
| Investing cash flow | $24.51M | $265.52M | $389.41M | -$762.23M | $227.84M | -90.8% |
| Financing cash flow | $27.18M | $29.51M | $33.86M | $33.41M | $857.81M | -7.9% |
| Free cash flow | -$95.09M | -$226.22M | -$264.19M | -$222.18M | -$209.05M | +58.0% |
| End cash position | $544.76M | $582.19M | $510.44M | $334.76M | $1.28B | -6.4% |
Options analytics
Put / call volume
0.17
Call-heavy session
Put / call open interest
0.23
Positioning, not flow
Max pain
115.00
+9.3% from spot
ATM implied vol
53.8%
Nearest strike to spot
Skew (10% OTM)
+0.1%
Puts bid over calls
Call volume
350
Contracts, this expiry
Put volume
60
Contracts, this expiry
Heaviest call OI
115.00
1.23K contracts
Heaviest put OI
125.00
262 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.68 | -0.06 | +91.2% |
| Mar 2026 | -1.00 | -0.76 | +23.9% |
| Dec 2025 | -1.17 | -1.54 | -31.9% |
| Sep 2025 | -1.37 | -1.75 | -27.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.36 | 17 | $500.94M | +251.9% |
| Next quarter | -0.30 | 17 | $568.63M | +115.5% |
| Current year | -1.54 | 18 | $1.81B | +198.1% |
| Next year | 0.77 | 18 | $2.88B | +59.0% |
Analyst targets & ownership
Mean target$197.74
High target$243.00
Low target$169.00
Implied upside85.67%
Analyst count23
ConsensusSTRONG BUY
Strong buy / Buy5 / 19
Hold0
Sell / Strong sell0 / 0
Held by insiders0.51%
Held by institutions105.05%
Institutions holding970
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
113.39
-6.08% from price
SMA 20
118.65
-11.31% from price
SMA 50
119.76
-12.14% from price
SMA 100
112.64
-5.45% from price
SMA 200
132.14
-20.36% from price
EMA 12
113.16
-5.88% from price
EMA 26
117.04
-9.01% from price
EMA 50
117.94
-9.70% from price
RSI (14)
33.4
Neutral
MACD (12,26,9)
-3.88
Hist -1.91
ATR (14)
5.23
4.97% of price
Realised vol 30D
40.3%
Annualised
Bollinger upper
132.74
20, 2σ
Bollinger lower
104.56
20, 2σ
50 / 200 cross
Death
119.76 vs 132.14
Trend bias
Below 200
-20.36%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.51
Less volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
40.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-56.5%
Peak to trough
Max drawdown 5Y
-56.5%
Peak to trough
ATR 14
5.23
4.97% of price
Beta (reported)
0.82
5Y monthly, from filing
Short interest
Shares short
10.80M
Prior 10.89M
Change vs prior
-0.8%
Shorts covering
% of float
5.57%
Normal
% of shares out
4.95%
Against total outstanding
Days to cover
5.7
Crowded exit
Float
216.93M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Sep 15, 26 | Roth Capital | MAINTAINED | Buy | Buy |
| Aug 10, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 10, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 7, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jul 21, 26 | BMO Capital | INITIATED | — | Outperform |
| Jul 15, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 10, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jun 22, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jun 8, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:10
Split dateMar 3, 2011
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-05
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-16
Offering Registrations
S-3ASR · 2026-05-15
Corporate Changes & Voting Matters
8-K · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-04-07
Annual Report to Shareholders
ARS · 2026-04-01
Corporate Changes & Voting Matters
8-K · 2026-03-23
Headlines
INSM Stock Slides on CFO Exit, Reiterates '26 Sales View
Zacks · 13h ago
Insmed stock falls as CFO Sara Bonstein to step down
Investing.com · 2d ago
Sector Update: Healthcare Stocks Steady Pre-Bell Monday
MT Newswires · 2d ago
Insmed Chief Financial Officer Sara Bonstein to Step Down
MT Newswires · 2d ago
Insmed Announces CFO Transition
PR Newswire · 2d ago
Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback
Zacks · 5d ago
Insmed (INSM) Gets Faster FDA Review. Can Its Lung Drug Reach More Patients?
Insider Monkey · 9d ago
What BioPharma Credit (BPCP) Said on Its H1 Earnings Call
MarketBeat · 12d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.